Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A mouse model for Sorsby fundus dystrophy.

Bernhard H F Weber1, Biaoyang Lin, Karen White

  • 1Institute of Human Genetics, Biocenter, University of Wuerzburg, Germany. bweb@biozentrum.uni-wuerzburg.de

Investigative Ophthalmology & Visual Science
|July 31, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spectrum of double heterozygosity in individuals diagnosed with hereditary breast and ovarian cancer.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Allele-specific suppression of pathogenic bestrophin-1 transcripts by CRISPR/Cas9-mediated genome editing.

Genome medicine·2026
Same author

Together, Shaping the Future: Our Collective Journey in Omics, Integrative Biology, AI, and the Future of Medicine.

Omics : a journal of integrative biology·2025
Same author

Patient-Reported Social Impact of Molecularly Confirmed Macular Dystrophies and Cone-Rod Dystrophies.

Journal of clinical medicine·2025
Same author

Bilateral Sector Macular Dystrophy Associated with <i>PRPH2</i> Variant c.623G>A (p.Gly208Asp).

Journal of clinical medicine·2025
Same author

Patient-Reported Social Impact of Molecularly Confirmed Retinitis Pigmentosa.

Journal of clinical medicine·2025

A new knock-in mouse model carrying a Sorsby fundus dystrophy-related mutation in the Timp3 gene shows early signs of retinal changes. These findings suggest excess tissue inhibitor of metalloproteinases-3, not deficiency, may drive the disease.

Area of Science:

  • Genetics
  • Ophthalmology
  • Molecular Biology

Background:

  • Sorsby fundus dystrophy (SFD) is a rare, late-onset macular dystrophy linked to mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) gene.
  • Known TIMP3 mutations create unpaired cysteine residues, leading to higher-molecular-weight protein complexes with unknown functional impacts in SFD pathogenesis.

Purpose of the Study:

  • To create a knock-in mouse model with a disease-related Ser156Cys mutation in the Timp3 gene for in vivo investigation of mutant TIMP3.
  • To characterize the molecular and pathological consequences of the Timp3(S156C) mutation in mice.

Main Methods:

  • Generation of mutant ES cells using site-directed mutagenesis and homologous recombination.
  • Production of chimeric mice and characterization using molecular genetic, biochemical, electron microscopic, and electrodiagnostic techniques.

Related Experiment Videos

Main Results:

  • Knock-in mice at 8 months exhibited abnormalities in Bruch's membrane and retinal pigment epithelium (RPE) basal microvilli.
  • Biochemical profiles of mutant TIMP3 were similar in mice and humans, indicating conserved molecular pathways.
  • Increased Timp3 levels were observed in Bruch's membrane of mutant mice, despite normal protein localization.

Conclusions:

  • The generated knock-in mice display early features mirroring age-related changes in Bruch's membrane and RPE, potentially representing primary SFD manifestations.
  • Data support a model where site-specific excess of functional TIMP3, rather than absence or deficiency, is the primary consequence of known TIMP3 mutations in SFD.